DK1556389T6 - Cephemforbindelser - Google Patents

Cephemforbindelser Download PDF

Info

Publication number
DK1556389T6
DK1556389T6 DK03758919.9T DK03758919T DK1556389T6 DK 1556389 T6 DK1556389 T6 DK 1556389T6 DK 03758919 T DK03758919 T DK 03758919T DK 1556389 T6 DK1556389 T6 DK 1556389T6
Authority
DK
Denmark
Prior art keywords
cephem
Prior art date
Application number
DK03758919.9T
Other languages
English (en)
Other versions
DK1556389T3 (da
Inventor
Hidenori C O Astellas Pharma Inc Ohki
Shinya C O Astellas Pharma Inc Okuda
Toshio C O Astellas Pharma Inc Yamanaka
Masaru C O Astellas Pharma Inc Ohgaki
Ayako C O Astellas Pharma Inc Toda
Kohji C O Astellas Pharma Inc Kawabata
Satoshi Wakunaga Pharmaceutical Co Ltd Inoue
Keiji Wakunaga Pharmaceutical Co Ltd Misumi
Kenji Wakunaga Pharmaceutical Co Ltd Itoh
Kenji Wakunaga Pharmaceutical Co Ltd Satoh
Original Assignee
Astellas Pharma Inc
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2002952355A external-priority patent/AU2002952355A0/en
Priority claimed from AU2003904813A external-priority patent/AU2003904813A0/en
Application filed by Astellas Pharma Inc, Wakunaga Pharma Co Ltd filed Critical Astellas Pharma Inc
Publication of DK1556389T3 publication Critical patent/DK1556389T3/da
Application granted granted Critical
Publication of DK1556389T6 publication Critical patent/DK1556389T6/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03758919.9T 2002-10-30 2003-10-27 Cephemforbindelser DK1556389T6 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002952355A AU2002952355A0 (en) 2002-10-30 2002-10-30 Cephem compounds
AU2003904813A AU2003904813A0 (en) 2003-09-04 Cephem Compounds
PCT/JP2003/013684 WO2004039814A1 (en) 2002-10-30 2003-10-27 Cephem compounds

Publications (2)

Publication Number Publication Date
DK1556389T3 DK1556389T3 (da) 2007-11-26
DK1556389T6 true DK1556389T6 (da) 2015-05-11

Family

ID=32231625

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03758919.9T DK1556389T6 (da) 2002-10-30 2003-10-27 Cephemforbindelser

Country Status (20)

Country Link
US (2) US7129232B2 (da)
EP (1) EP1556389B9 (da)
JP (1) JP4448821B2 (da)
KR (1) KR101023035B1 (da)
AR (1) AR041729A1 (da)
AT (1) ATE368042T1 (da)
BE (1) BE2016C002I2 (da)
BR (1) BRPI0315188B8 (da)
CA (1) CA2504730C (da)
DE (1) DE60315178T3 (da)
DK (1) DK1556389T6 (da)
ES (1) ES2290498T7 (da)
FR (1) FR16C0004I2 (da)
HK (1) HK1086566A1 (da)
HU (1) HUS1600008I1 (da)
LU (1) LU92943I2 (da)
NL (1) NL300793I2 (da)
PT (1) PT1556389E (da)
TW (1) TWI319403B (da)
WO (1) WO2004039814A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090364A1 (en) * 2001-05-01 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
PT1556389E (pt) * 2002-10-30 2007-11-08 Wakunaga Pharma Co Ltd Compostos de cefeme
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CN1852715A (zh) 2003-09-18 2006-10-25 安斯泰来制药有限公司 头孢类化合物
EP1698375B1 (en) * 2003-12-25 2014-04-02 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
JP2009530228A (ja) * 2006-03-16 2009-08-27 アステラス製薬株式会社 セフェム化合物および抗菌薬としての利用
ITFE20060029A1 (it) * 2006-10-17 2008-04-18 Gruppo Kemon Spa Intermedi eterociclici primari per la colorazione ossidativa dei capelli a struttura pirazolica
WO2009049086A1 (en) 2007-10-09 2009-04-16 Larry Sutton Broad spectrum beta-lactamase inhibitors
AU2012256237B2 (en) 2011-05-13 2017-01-05 Array Biopharma Inc. Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as TrkA kinase inhibitors
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
EP2628730B1 (en) * 2012-02-16 2017-12-06 Noxell Corporation Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salts
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US20150306076A1 (en) 2012-09-27 2015-10-29 Cubist Pharmaceuticals, Inc. Tazobactam arginine antibiotic compositions
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274999A1 (en) * 2013-03-14 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin compositions and methods of manufacture
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (es) * 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20160228448A1 (en) * 2013-09-27 2016-08-11 Merck Sharp & Dohme Corp. Solid Forms of Ceftolozane
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2015051101A1 (en) 2013-10-02 2015-04-09 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
PL3154959T3 (pl) 2014-05-15 2019-12-31 Array Biopharma, Inc. 1-((3S,4R)-4-(3-Fluorofenylo)-1-(2-metoksyetylo)pirolidyn-3-ylo)-3-(4-metylo-3- (2- metylopirymidyn-5-ylo)-1-fenylo-1H-pirazol-5-ilo)-mocznik jako inhibitor kinazy TrkA
US10221196B2 (en) 2014-08-15 2019-03-05 Merck Sharp & Dohme Corp. Intermediates in the synthesis of cephalosporin compounds
WO2016025839A1 (en) 2014-08-15 2016-02-18 Merck Sharp & Dohme Corp. Synthesis of cephalosporin compounds
WO2016028670A1 (en) * 2014-08-18 2016-02-25 Merck Sharp & Dohme Corp. Salt forms of ceftolozane
WO2016095860A1 (en) * 2014-12-18 2016-06-23 Merck Sharp & Dohme Corp. Pyrazolyl carboxylic acid and pyrazolyl urea derivative compounds
US10059680B2 (en) 2014-12-18 2018-08-28 Merck Sharp & Dohme Corp. Thiadiazolyl-oximinoacetic acid derivative compounds
US20160176897A1 (en) 2014-12-23 2016-06-23 Merck Sharp & Dohme Corp. 7-aminocephem derivative compounds
WO2016109259A2 (en) * 2014-12-30 2016-07-07 Merck Sharp & Dohme Corp. Synthesis of cephalosporin compounds
ES2729026T3 (es) 2015-06-29 2019-10-29 Sandoz Ag Procedimiento para la preparación de derivados de carbamoilamino pirazol
WO2017042188A1 (en) 2015-09-08 2017-03-16 Sandoz Ag Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-aca)
US9751894B2 (en) 2015-12-10 2017-09-05 Naeja-Rgm Pharmaceuticals Inc. Cephem compounds, their production and use
ES2973874T3 (es) 2016-06-06 2024-06-24 Merck Sharp & Dohme Llc Formas sólidas de ceftolozano y procesos para su preparación
CN107586305A (zh) * 2017-06-23 2018-01-16 浙江惠迪森药业有限公司 一种β‑内酰胺类化合物羧基及羟基保护基脱除方法
WO2019145784A2 (en) * 2018-01-26 2019-08-01 Legochem Biosciences, Inc. Combination therapies for multi-drug resistant pathogens
CN109369535A (zh) * 2018-11-07 2019-02-22 浙江东邦药业有限公司 一种氨基甲酰氨基吡唑衍生化合物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78245B (da) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
US5210080A (en) * 1987-09-07 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
IE63094B1 (en) * 1987-09-14 1995-03-22 Fujisawa Pharmaceutical Co Cephem compound and a process for preparation thereof
US5173485A (en) * 1988-03-09 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Cephem compounds
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
US5215982A (en) * 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
KR910015587A (ko) * 1990-02-27 1991-09-30 후지사와 토모키치로 세펨 화합물
GB9023479D0 (en) * 1990-10-29 1990-12-12 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
JPH09110877A (ja) 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
AUPN955596A0 (en) 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
WO2002090364A1 (en) * 2001-05-01 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
PT1556389E (pt) * 2002-10-30 2007-11-08 Wakunaga Pharma Co Ltd Compostos de cefeme
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CN1852715A (zh) * 2003-09-18 2006-10-25 安斯泰来制药有限公司 头孢类化合物

Also Published As

Publication number Publication date
ES2290498T7 (es) 2015-07-10
FR16C0004I1 (fr) 2016-03-25
DE60315178T2 (de) 2008-04-30
DE60315178D1 (de) 2007-09-06
US20040132994A1 (en) 2004-07-08
FR16C0004I2 (fr) 2017-01-06
JP2006506459A (ja) 2006-02-23
HK1086566A1 (en) 2006-09-22
US20070037786A1 (en) 2007-02-15
EP1556389B1 (en) 2007-07-25
KR101023035B1 (ko) 2011-03-24
DK1556389T3 (da) 2007-11-26
JP4448821B2 (ja) 2010-04-14
ES2290498T3 (es) 2008-02-16
ATE368042T1 (de) 2007-08-15
TW200410977A (en) 2004-07-01
LU92943I2 (fr) 2016-03-14
CA2504730A1 (en) 2004-05-13
TWI319403B (en) 2010-01-11
CA2504730C (en) 2011-04-12
EP1556389A1 (en) 2005-07-27
HUS1600008I1 (hu) 2016-03-29
EP1556389B9 (en) 2015-09-09
NL300793I1 (da) 2016-03-15
BE2016C002I2 (da) 2023-03-07
EP1556389B3 (en) 2015-04-01
US7129232B2 (en) 2006-10-31
WO2004039814A1 (en) 2004-05-13
NL300793I2 (da) 2016-03-15
PT1556389E (pt) 2007-11-08
KR20050084897A (ko) 2005-08-29
DE60315178T3 (de) 2015-06-18
AR041729A1 (es) 2005-05-26
BRPI0315188B1 (pt) 2017-04-25
BRPI0315188B8 (pt) 2021-05-25
BR0315188A (pt) 2005-09-06

Similar Documents

Publication Publication Date Title
DK1556389T3 (da) Cephemforbindelser
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
ATE427876T1 (de) Luftkissenboot
DE50310083D1 (de) Phthalocyaninpigmentzubereitungen
ATE318817T1 (de) Aza-arylpiperazine
DE50212360D1 (de) Anfahrhilfesteuerungsvorrichtung
DE50212349D1 (de) Hirurgie
DE50301200D1 (de) Wischblatt
DE60326590D1 (de) Tend lamotrigin
DE602004026451D1 (de) Cephem-verbindungen
ATE349458T1 (de) Etonogestrelester
DE50305301D1 (de) Einspritzventil
ATA1572002A (de) Managementspleisskassette
DE50301960D1 (de) Hydrolager
DE50302660D1 (de) Stopfmachine
DE50301464D1 (de) Schraubensicherung
ATA4142004A (de) Trägerverbau
ATE469773T1 (de) Zugöse
DE50303317D1 (de) Einschub-leistungsschalter
ATA19152002A (de) Hubkupplung
NO20033410D0 (no) Pressverktöy
ATE396192T1 (de) N-sulfonylaminothiazole
DE50303658D1 (de) Postgutmessvorrichtung
DE50300322D1 (de) Zylinderkopfdichtung